A next-generation CRO dedicated to empowering pharmaceutical enterprises and research institutions worldwide through integrated, disease biology–driven R&D solutions.
TriApex US Lab is equipped with three main technical platforms to offer concentration analysis and immunogenicity evaluation services for bio-therapeutic products. Our services span early-phase research, nonclinical studies, and clinical trials, including cell and gene level analysis, immunoassays, and biomarker studies.